We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Field Test Allows Rapid Diagnosis of Chikungunya Virus Infection

By LabMedica International staff writers
Posted on 12 Oct 2016
Chikungunya virus (CHIKV) infection causes symptoms that are similar to Dengue and Zika as well as other viral diseases, including influenza and accurate diagnosis of CHIKV is important for effective outbreak responses, including patient management and mosquito control.

A reverse transcriptase (RT) recombinase polymerase amplification (RPA) assay has been developed for rapid detection of CHIKV in clinical samples. More...
RPA-based detection of small amounts of DNA is an alternative to polymerase chain reaction (PCR) and based on reactions that can run at constant temperatures.

An international team of scientists led by those at the Robert-Koch-Institute (Berlin, Germany) included in their study 78 patients with a history of sudden onset of fever, headache, fatigue, nausea, vomiting, rash, myalgia and severe and very painful polyarthralgia suggestive of CHIK infection. Fifty-eight plasma samples were provided by a group in Thailand and 20 CHIKV positive sera samples collected from patients suspected to be infected by CHIKV during routine medical examination, were provided by French scientists.

The team designed a set of CHIKV-specific reagents and showed that the assay was able to detect very small amounts of CHIKV ribonucleic acid (RNA). The RT-RPA assay was slightly less sensitive than RT-PCR, but both assays yielded identical results on clinical samples of 20 patients with known CHIKV infection and 58 samples from suspected cases.

Testing the RT-RPA assay on different CHIKV strains and a panel of related alpha - and arboviruses, the scientists found, that the assay reliably detected all 18 different CHIKV strains tested. In addition, there was no cross-reactivity of the assay with any of the other tested viruses except for the very closely related O'nyong'nyong virus (ONNV). Using a modified set of assay reagents, the scientists were able to eliminate the problem of false-positive results caused by ONNV. The diagnostic sensitivity and specificity of the CHIKV RT-RPA assay were determined at 100%.

The investigators highlighted that RPA reagents are stable at ambient temperature (25-38 °C), meaning they do not need to be refrigerated. The authors concluded that the CHIKV RPA assay is a promising tool for CHIKV diagnostics at the point of need. Integration into a multimer or multiplex assay for simultaneous and detection of CHIKV, Dengue virus and Zika virus as well as an internal control would improve outbreak investigations, since the three viruses induce same clinical picture upon infection and increasingly co-circulate in many parts of world. The study was published on September 29, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Robert-Koch-Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.